newsfilter
← Latest News
GlobeNewswire·

Chiasma Reports First Quarter Financial Results and Announced Agreement to Merge with Amryt

Announced agreement to merge with Amryt Combination to create a global commercial stage rare and orphan disease leader with a diversified portfolio of therapies and a meaningful late-stage development pipeline Q1 2021 Net Product Revenues of $1